Liver Fibrosis: Perspectives in Pathobiochemical Research and Clinical Outlook

Clinical Chemistry and Laboratory Medicine

Volumn 29, Issue 5, 1991, Pages 293-312

  Gressner, A M ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; LIVER FIBROSIS; PRIORITY JOURNAL; REVIEW;

CONNECTIVE TISSUE; EXTRACELLULAR MATRIX; HUMAN; LIVER CIRRHOSIS; PROTEOGLYCANS;

EID: 84955869519     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.1991.29.5.293     Document Type: Review

References (145)

1. De Vos, M., Barbier, F. & Cuvelier, C. (1988) Congenital hepatic fibrosis. J. Hepatol. 5, 222-228.
2. Lafon, M. E., Bioulac-Sage, P. Grimaud, J. A., Boussarie, L., Merlio, J. P. & Reiffers, J. (1987) Perisinusoidal. fibrosis of the liver in patients with thrombocytopenic purpura. Virchows Arch. A 411, 553-559.
3. Lafon, M. E., Bioulac-Sage, P. & Balabaud, C. (1988) Hepatic fibrosis in patients with idiopathic thrombocytopenic purpura. Liver 8, 24—27.
4. Degott, C., Capron, J. P., Bettan, L., Molas, G., Bernuau, D., Polet, F., Feldman, G. & Benhamou, J. P. (1985) Myeloid metaplasia, perisinusoidal fibrosis, and nodular regenerative hyperplasia of the liver. Liver 5, 276—281.
5. Latry, P., Bioulac-Sage, P., Echinard, E., Gin, H., Boussaric. L., Grimaud, J. A. & Balabaud, C. (1987) Perisinusoidal fibrosis and basement membrane-like malerial in the livers of diabetic patients. Hum. Pathol. 18, 775-780.
6. Nalaf, C., Feldmann, G., Lebrec, D., Degott, C., Descamps, J.-M., Rueff, B. & Benhamou, J.-P. (1979) Idiopathic portal hypertension (perisinusoidal fibrosis) after renal transplantation. Gut 20, 531—537.
7. Popper, H., Davidson, C. S., Leevy, C. M. & Schaffner, F. (1969) The social impact of liver disease. New Engl. J. Med. 281, 1455-1458.
8. Boyer, J. L. & Bianchi, L. (1986) Liver cirrhosis. Proceedings of the 44th Falk Symposium, pp. 1-5, MTP Press Ltd., Lancaster, England.
9. Statistisches Bundesamt Wiesbaden (1987) Sterbefälle nach Todesursachen (Einzelnachweis), p. 41.
10. Martini, G. A. & Bode, Ch. (1970) Zur Epidemiologie der Leberzirrhose. Internist 11, 84—93.
11. Anthony, P. P., Ishak, K. G., Nayak, N. C., Poulsen, H. E., Scheuer, P. J. & Sobin, L. H. (1978) The morphology of cirrhosis. J. Clin. Pathol. 31, 395-414.
12. Sherman, I. A., Pappas, S. C. & Fisher, M. M. (1990) Hepatic microvascular changes associated with development of liver fibrosis and cirrhosis. Am. J. Physiol. 258, H460-H465.
13. Thompson, W.D., Jack, A. S. & Patrick, R. S. (1980) The possible role of macrophages in transient hepatic fibrogenesis-induced by acute carbon tetrachloride injury. J. Pathol. 130, 65-73.
14. Michalopoulos, G. K. (1990) Liver regeneration: Molecular mechanisms of growth control. FASEB J. 4, 176-187.
15. Rojkind, M., Giambrone, M. A. & Biempica, L. (1979) Collagen types in normal and cirrhotic liver. Gastroenterology 76, 710-715.
16. Schuppan, D. (1990) Structure of the extracellular matrix in normal and fibrotic liver: Collagens and glycoproteins. Sem. Liver Dis. 10, 1-10.
17. Biagini, G. & Ballardini, G. (1989) Liver fibrosis and extracellular matrix. J. Hepatol. 8, 115 — 124.
18. Kittelberger, R., Davis, P. F., Flynn, D. W. & Greenhill, N. S. (1990) Distribution of type VIII collagen in tissues: An immunohistochemical study. Connective Tissue Res. 24, 303-318.
19. Lozzo, R. V. (1985) Biology of disease. Proteoglycans: Structure, function and role in neoplasia. Lab. Invest. 55, 373-396.
20. Ruoslahti, E. (1989) Proteoglycans in cell regulation. J. Biol. Chem. 264, 13369-13372.
21. Ruoslahti, E. (1988) Structure and biology of proteoglycans. Ann. Rev. Cell Biol. 4, 229-255.
22. Akiyama, S. K., Nagata, K. & Yamada, K. M. (1990) Cell surface receptors for extracellular matrix components. Biochim. Biophys. Acta 1031, 19-110.
23. Vogel, K. G., Paulsson, M. & Heinegard, D. (1984) Specific Inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem. J. 225, 587-597.
24. Martinez-Hernandez, A. (1985) The hepatic extracellular matrix. Electron immunohistochemical studies in rats with CCLrinduced cirrhosis. Lab. Invest. 55, 166-186.
25. Gressner, A. M. & Bachern, M. G. (1990) Cellular sources of noncollagenous matrix proteins: Role of fat-storing cells in fibrogenesis. Sem. Liver Dis. 10, 30—46.
26. Friedman, S. L. (1990) Cellular sources of collagen and regulation of collagen production in liver. Sem. Liver Dis 10, 20-29.
27. Hendriks, H. F. J., Brouwer, A. & Knook, D. L. (1987) The role of hepatic fat-storing (stellate) cells in retinoid metabolism. Hepatology 7, 1368 — 1371.
28. Mak, K. M. & Lieber, C. S. (1988) Lipocyles and transitional cells in alcoholic liver disease: A morphometric study. Hepatology 8, 1027-1033.
29. Mak, K. M., Leo, M. A. & Lieber, C. S. (1984) Alcoholic liver injury in baboons: Transformation of lipqcytes to transitional cells. Gastroenterology 87, 188 — 200.
30. Friedman, S. L., Roll, F. J., Boyles, J. & Bissell, D. M. (1985) Hepatic lipocytes: The principal collagen-producing cells of normal rat liver. Proc. Natl. Acad. Sci. 82, 8681-8685.
31. Arenson, D. M., Friedman, S. JL. & Bissell, D. M. (1988) Formation of extracellular matrix in normal rat liver: Lipocytes as a major source of proteoglycan. Gastroenterology 95, 441-447.
32. Schäfer, S., Zerbe, O. & Gressner, A. M. (1987) The synthesis of proteoglycans in fat-storing cells of rat liver. Hepatology 7, 680-687.
33. Ramadori, G., Rieder, H., Knittel, Th., Dienes, H. P. & Meyer zum Büschenfelde, K. H. (1987) Fat storing cells (FSC) of rat liver synthesize and secrete flbrönectin. J. Hepatol. 4, 190-197.
34. Mäher, J. J., Friedman, S. L., Roll, F. J. & Bissell, D. M. (1988) Immunolocalization of lamrain in normal rat liver and biosynthesis of laminiri by hepatic lipocytes in primary culture. Gastroenterology 94, 1053-1062.
35. Ramadori, G., Schwögler, S., Veit, Th., Rieder, H. & Meyer zum Büschenfelde, K.-H. (1990) Fettspeicherzellen (Ito-Zellen) der Rattenleber synthetisieren und sezernieren Entactin (Nidogen). Vergleich mit anderen Leberzellen. Z. Gastroenterol. XXVlII, p. 56 (Abstract).
36. Eyken Van, P, Geerts, A., Lazou, J. M., De Bleser, P., Sciot, R., Desmet, V. & Wisse, E. (1990) Distribution of the novel extracellular matrix glycoprotein tenascin in normal and CC14 rajured rat liver: An immunohistochemical study. In: 5th International Symposium on Cells ofthe Hepatic Sinusoid, Tucson, Arizona, U. S. A. (Abstract).
37. Gressner, A. M. & Haarmann, R. (1988) Hyajuronic acid synthesis and secretion by rat liver fat-storing cells (perisinusoidal lipocytes) in culture. Biochem. Biophys. Res. Commun. 757, 222-229.
38. Geerts, A., Vrijsen, Ri, Rauterberg, J., Burt, A., Schellinck, P. & Wisse, E. (1989) In vitro differentiation of fatstoring cells parallels marked increase of collagen synthesis and secretion. J. Hepatol. 9, 59—68.
39. Gressner, A. M. (1991) Time-related distributipn profiles of sulfated glycosaminoglycans in cells, cell surfaces and rnedia of cultured rat liver fat-storing cells. Proc. Soc. Exp. Biol. Med. 196, 307-315.
40. Horn, T., Junge, J. & Christoffersen, P. (1986) Early alcoholic liver injury. Activation of lipocytes in acinar zone 3 and correlation to degree of collagen förmation in the Disse space. J. Hepatol. 5, 333-340.
41. Weiner, F. R., Giambrone, M. A., Czaja, M. J., Shah, A., Annoni, G., Takahashi, S., Eghbali, M. & Zern, M. A. (1990) Ito-cell gene expression and collagen regulation. Hepatology 11, 111-117.
42. Chojkier, M. & Filip, M. (1986) Hepatocyte collagen prodüction in vivo in normal rats. J. Clin. Invest. 78, 333-339.
43. Chojkier, M., Lyche, K. D. & Filip, M. (1988) Increased production of collagen in vivo by hepatocytes and nonparenchymal cells in rats with carbon tetrachloride-induced hepatic fibrosis. Hepatology 8, 808 — 814.
44. Brenner, D. A., Alcorn, J. M., Feitelberg, S. P., Leftert, H. L. & Chojkier, M. (1990) Expression of collagen genes in the liver. Mol. Biol. Med. 7, 105-115.
45. Yamada, H., Aida, T, Taguchi, K. & Asano, G. (1989) Localization of type III procollagen mRNA in areas of liver fibrosis by in situ hybridization. Acta Pathol. Jap. 59,719-724.
46. Milani, S., Herbst, H., Schuppan, D., Surrenti, C., Riecken Riecken. E. & Stein, H. (1990) Cellular localization of type I, III and IV procollagen gene transcripts in normal and fibrotic human liver. Amer. J. Pathol. 137, 59-70.
47. Milani, S., Herbst, H., Schuppan, D., Hahn, E. G. & Stein, H. (1989) In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: Evidence for predominant expression in nonparenchymal liver cells. Hepatology 10, 84-92.
48. Milani, S., Herbst, H., Schuppan, D., Kim, K. Y., Riecken, E. O. & Stein, H. (1990) Procollagen expression by nonparenchymal rat liver cells in experimental biliary fibrosis. Gastroenterology 98, 175 — 184.
49. Nakatsukasa, H., Nagy, R. Evarts, R. P., Hsia, C. C., Marsden, E. & Thorgeirsson, S. S. (1990) Cellular distribution of transforming growth factor-β1 and procollagen types I, III, and IV transcripts in carbon tetrachlorideinduced rat liver fibrosis. J. Clin. Invest. 85, 1833 — 1843.
50. Meyer, D. H., Zimmermann, T., Müller, D., Franke, H., Dargel, R. & Gressner, A. M. (1990) The synthesis of glycosaminoglycans in isolated hepatocytes during experimental liver fibrogenesis. Liver 10, 94—105.
51. Armendariz-Borunda, J., Greenwel, P. & Rojkind, M.(1989) Kupffer cells from CCU-treated rat livers induce skin fibroblast and liver fat-sloring cell proliferation in culture. Matrix 9, 150-158.
52. Friedman, S. L. & Arthur, J. P. (1989) Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. J. Clin. Invest. 84, 1780-1785.
53. Gressner, A. M. & Haarmann, R. (1988) Regulation of hyaluronate synthesis in rat liver fat-storing cell cultures 1 by Kupffer cells. J. Hepatol. 7, 310-318.
54. Gressner, A. M. & Zerbe, O. (1987) Kupffer cell-mediated induction of synthesis and secretion of proteoglycans by rat liver fat-storing cells in culture. J. Hepatol. 5, 299 — 310.
55. Matsuoka, M., Zhag, M. Y. & Tsukamoto, H. (1989) Sensitization of hepatic lipocytes by high-fat diet to stimulatory effects of Kupffer cell-derived factors: Implication in alcoholic liver fibrogenesis. Hepatology 11, 173 — 182.
56. Shiratori, Y, Geerts, A., Ichida, T., Kawase, T. & Wisse, E. (1986) Kupffer cells from CCl4-induced fibrotic livers stimulate proliferation of fat-storing cells. J. Hepatol. 3, 294-303.
57. Zerbe, O. & Gressner, A. M. (1988) Proliferation of fatstoring cells is stimulated by secretions of Kupffer cells from normal and injured liver. Exp. Molec. Pathol. 49, 87-101.
58. Matsuoka, M. & Tsukamoto, H. (1990) Stimulation of hepatic lipocyte Collagen production by Kupffer cell-derived transforming growth factor ß: Implication of a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 11, 599-605.
59. Meyer, D. H., Bachern, M. G. & Gressner, A. M. (1990) Modulation of hepatic lipocyte proteoglycan synthesis and proliferation by Kupffer cellrderived transforming growth factors type β1 and type α. Biochem. Biophys. Res. Commun. 171, 1122-1129.
60. Vanderkerken, K., Bouwens, L. & Wisse, E. (1990) Characterization of a phenotypically and functionally distinct subset of large granulär lymphocytes (pit cells) in rat liver sinusoids. Hepatology 12, 70—75.
61. Rosenbaum, J., Mavier, R & Preaux, A. M. (1989) Mouse hepatic endothelial cells in culture secrete a growth inhibitor for lipocytes and Balb/c 3T3 fibroblasts. J. Hepatol. 9, 295-300.
62. Gressner, A. M. (1989) Effects of conditioned media from normal and regenerating-hepatocytes on proliferation and proteoglycan synthesis of rat liver fat storing cells in culture. Biol. Chem. Hoppe-Seyler 370, 902-903.
63. Bachern, M. G., Melchior, R. & Gressner, A. M. (1989) The role of thrombocytes in liver fibrogenesis: Effects of platelet lysate and thrombocyte-derived growth faotors on the mitogenic activity and glycosaminoglycan synthesis of cultured rat liver fat-storing cells. J. Clin. Chem. Clin. Biochem. 27, 555-565.
64. Andus, T, Ramadori, G., Heinrich, P. C., Knittel, T. & Meyer zum Büschenfelde, K. H. (1987) Cultured Ito cells of rat liver express the α2-macroglobulin gene. Eur. J. Biochem. 168, 164-646.
65. LaMarre, J., Wollenberg, G. K., Gauldie, J. & Hayes, M. A. (1990) α2-Macroglobulin and scrum prefercntially counteract the rnitoinhibitory effect of transforming growth factor-β2 in rat hcpatocytes. Lab. Invest. 62, 545- 551.
66. McCaffrey, T. A., Falcone, D. J., Brayton, C. F., Agarwal, L. A., Welt, F. G. P. & Weksler, B. B. (1989) Transforming growth factor-β activity is potentiated by heparin via dissociation of the transforming growth factor-β/α2-macroglobulin inactive complex. J. Cell Biol. 109, 441 —448.
67. Yamaguchi, Y., Mann, D. M. & Ruoslahti, E. (1990) Negative regulation of transforming growlh factor β by the proteoglycan decorin. Nature 346, 281 -284.
68. Ruoslahti, E. & Yamaguchi, Y. (1991) Proteoglycans as Modulators of Growlh Factor Activities. Cell 64, 867-869.
69. Shiratori, Y., Ichida, T, Kawase, T. & Wisse, E. (1986) Effect of acetaldehyde on Collagen synthesis by fat-storing cells isolated from rats treated with carbon tetrachloride. Liver 6, 246-251.
70. Moshage, H., Casini, A. & Lieber, C. S. (1990) Acetaldehyde sclectively stimulates Collagen production in cultured rat liver fat storing cells but not in hepatocytes. Hepatology 12, 511-518.
71. Brenner, D. A. & Chojkier, M. (1987) Acetaldehyde increase Collagen gene transcription in cultured human fibroblasts. J. Biol. Chem. 262, 17690-17695.
72. Chojkier, M., Solis-Herruzo, J. A. & Brenner, D. A. (1988) Lipid peroxidation stimulates collagen gene expression. A common pathway for fibrogenesis? Gastroenterology 94, A529 (Abstract).
73. Yamada, S., Yamada, M., Murawaki, Y. & Hirayama, C. (1990) Increase in lipoperoxidase and prolyl hydroxylase activity in rat liver following chronic ethanol feeding. Biochem. Pharmakol. 40, 1015-1019.
74. Bachem, M. G., Meyer, D., Melchior, R., Sell, K.-M. & Gressner, A. M. (1991) Activation of rat liver fat-storing cells by myofibroblast-likc cell-derived transforming growth factors — A potential mechanism of seif perpetuation in liver fibrogenesis. J. Clin. Invest., in press.
75. Heinrich, P. C., Castell, J. V. & Andus, T. (1990) Interieukin-6 and the acule phase response. Biochem. J. 265,621 — 636.
76. Friedman, S. L.„ Roll, F. J., Boyles, J., Arenson, D. M. & Bissell, D. M. (1989) Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J. Biol. Chem. 264, 10756-10762.
77. Davis, B. H. (1988) Transforming growth factor β responsiveness is modulated by the extracellular collagen matrix during hepatic Ito cell culture. J. Cell. Physiol. 136, 547 — 553.
78. Davis, B. H., Pratt, B. M. & Madri, A. (1987) Retinol and extracellular collagen matrices modulate hepatic Ito cell collagen phenotype and cellular retinol binding protein levels. J. Biol. Chem. 262, 10280-10286.
79. Aronson, N. N. & Davidson, E. A. (1968) Catabolism of mucopolysaccharides by rat liver lysosomes in vivo. J. Biol. Chem. 243, 4494-4499.
80. Hutterer, F. (1968) Degradation of mucopolysaccharides by hepatic lysosomes in vivo. Biochim. Biophys. Acta 115, 312-319.
81. Weber, W. Kehrer, T. Gressner, A. M., Stuhlsatz, H. W. & Greiling, H. (1983) The changes of proteoglycan degrading lysosomal enzyme aclivities in parenchymal and non-parenchyraal liver cells and in scrum of rats during the development of experimental liver fibrosis. J. Clin. Chem. Clin. Biochem. 21, 287-293.
82. Arthur, M. J. P., Friedman, S. L., Roll, F. J. & Bissell, D. M. (1989) Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen. J. Clin. Invest. 84, 1076-1085.
83. Smedsrod, B., Pertoft, H., Gustafson, S. & Laurent, T. C. (1990) Scavenger functions of the liver endothelial cell. Biochem. J. 266, 313-327.
84. Abccassis, M., Falk, J. A., Makowka, L., Dindzans, V. J., Falk, R. E. & Levy, G. A. (1987) 16,16-Dimethyl proslaglandin E2 prcvcnts the dcvclopment of fulminant hepalitis and blocks thc induction of monocyte/macrophage procoagulant activity after rnurine Hepatitis virus strain 3 infection, J. Clin. Invesl. SO, 881-889.
85. Ruwart, M. J., Rush, B. D., Friedle, N. M., Stachura, J. & Tarnawski, A. (1984) l6,16-Dimethyl-PGE2 protection against -naphthylisothiocyanate-induced experimental cholangitis in the rat. Hepatology 4, 658—660.
86. Bursch, W., Taper, H. S., Somer, M. P., Meyer, S., Putz, B. & Schulte-Hermann, R. (1989) Histochemical and biochemical studies on the effect of the prostacyclin derivative iloprost on CCU-induced lipid peroxidation in rat liver and its significance for hepatoprotection. Hepatology 9, 830-838.
87. Noda, Y., Hughes, R. D. & Williams, R. (1986) Effect of prostacyclin (PGI2) and a prostaglandin analogue BW 245C on galactosamine-induced hepatic necrosis. J. Hepatol. 2, 53-64.
88. Ruwart, M. J., Rush, B. D., Snyder, K. F., Peters, K. M., Appelman, H. D. & Henley, K. S. (1988) 16,16-Dimethyl prosiaglandin E2 delays collagen formation in nutritional injury in rat liver. Hepatology 8, 61 —64.
89. Peters, K. M., Snyder, K. F., Rush, B. D., Ruwart, M. J. & Henley, K. S. (1989) 16,16-Dimethyl prostaglandin E2 decreases the formation of collagen in flbrotic rat liver slices. Prqstaglandins 37, 445-456.
90. Van Gool, J., Boers, W. & De Nie, I. (1978) Inhibitory effects of rat α2 macrofetoprotein (αMFP), an acute phase globulin, on galactosamine hepatitis. Exp. Molec. Pathol. 29, 228-240.
91. Van Gool, J., Van Vugt, H. & De Nie, I. (1986) Acute phase reactants enhance CC14 induced liver cirrhosis in the rat. Exp. Molec. Pathol. 449 157-168.
92. Van Gool, J., Van Tiel, D., Doenhoff, M. J. & Van Vugt, H. (1991) Effect of acute phase proteins, especially oc2- macroglobulin, on granuloma formation around Schistosoma mansoni eggs in the rat. Parasitology, in press.
93. Van Gool, JL, De Nie, I., Smit, J. & Zuyderhoudt, F. J. J. (1986) Mechanisms by which acute phase proteins enhance development of liver fibrosis: Effects on collagenase and prolyl-4-hydroxylase activity in rat Hver. Exp. Molec. Pathol. 45, 160-170.
94. Van Gool, J., De Vie, I., Van Vugt, H. & Brugman, A. M. (1988) Relation between acute phase proteins and enhanced bleomycin-induced pulmonary fibrosis in the rat. Exp. Molec. Pathol. 49, 410-420.
95. Gregoriadis, G. (ed.) Liposomes as drug carriers. John Wiley & Sons Ltd., New York.
96. DeLoach, J. R. & Sprandel, U (eds.) (1985) Red blood cells as carriers for drugs. Bibliotheca Haematologica. No. 51 (Hässig, A., series ed.) S. Karger, Basel-New York.
97. Koch, M., Andersen-Beckh, B. & Gressner, A. M. (1989) Influence of acute liver injury on the organ distribution of drug-loaded erythrocyte carriers. J. Clin. Chem. Clin. Biochem. 27, 749-750 (Abstract).
98. Beutler, E., Dale, G. L., Guinto, E. & Kühl, W. (1977) Enzyme replacement therapy in Gaucher’s disease: Preliminary clinical trial of a new enzyme preparation. Proc. Natl. Acad. Sci. USA 74, 4620-4623.
99. Dale, G. L., Kühl. W. & Beutler, E. (1979) Incorporation of glucocerebrosidase into Gaucher’s disease monocytes in vitro. Proc. Natl. Acad. Sci. USA 76, 473-475.
100. De Flora, A., Benatti, U, Guida, L. & Zocchi, E. (1986) Encapsulation of adriamycin in human erythrocytes. Proc Natl. Acad. Sci. USA 83, 7029-7033.
101. Zocchi, E., Tonetti, M., Polvani, C., Guida, L., Benatti, U. & De Flora, A. (1989) Encapsulation of doxorubicin in liver-targeted erythrocytes increases the therapeutic index of the drug in a murine metastatic model. Proc. Natl. Acad. Sci. USA 86, 2040-2044.
102. Bickel, M., Baader, E., Brocks, D. G., Burghard, H., Günzier, V, Engelbart, K., Hanauske-Abel, H. M. & Vogel, G. (1990) Liver selective fibrosis suppression in the rat by a derivative of pyridine-2,4-dicarboxylate. Gastroenterology 98, A570 (Abstract).
103. Bickel, M., Baader, E., Brocks, D. G., Engelbart, K., Günzier, V, Schmidts, H.-L. & Vogel, G. (1990) Beneficial effects of inhibitors of prolyl,4-hydroxylase in CCl4-induced fibrosis of the liver in rats. In: Liver selective flbro suppression. A new approach in therapy of liver ßbrosis. Symposium preceeding the EASL-Meeting, Budapest.
104. Böker, K., Schwarting, G., Kaule, G., Günzler, V. & Schmidt, E. (1990) Fibrosis of the liver in rats induced by bile duct ligation. In: Liver selective flbrosuppression. A new approach in therapy of liver ßbrosis. Symposium preceeding the EASL-Meeting, Budapest.
105. Chojkier, M. & Brenner, D. A. (1988) Therapeutic strategies for hepatic fibrosis. Hepatology 8, 176—182.
106. Gressner, A.M., & Bachern, M. G. (1989) Mechanismen der Fibrogenese bei chronischer Leberentzündung. Z. Klin. Med. 44, 377-385.
107. Maharaj, B., Leary, W. R., Naran, A. D., Maharaj, R. J., Cooppan, R. M., Pirie, D. & Pudifn, D. J. (1986) Sampling variability and its influence on the diagnostic yield of pefcütaneous needle biopsy of the liver. Lancet, 523 — 555.
108. Risteli, L. & Risteli, J. (1990) Noninvasive methods for detection of organ fibrosis. In: Connective Tissue in Health and Disease (Rojkind, M., ed.) pp. 61-98, CRC Press Inc., Boca Ratton, USA.
109. Risteli, L. & Risteli, J. (1986) Radioimmunoassays for monitoring connective tissue metabolism. Rheumatology 10, 216-245.
110. Horslev-Petersen, K. (1990) Circulating extracellular matrix components as markers for connective tissue response to inflammations. Danish Medical Bulletin 37, 308 — 329.
111. Schuppan, D. (1991) Connective Tissue Polypeptides in Serum äs Parameters to Monitor Antifibrotic Treatment in Hepatic Fibrogenesis. J. Hepatol., in press.
112. Hayasaka, A., Schuppan, D., Ohnishi, K., Okuda, K. & Hahn, E. G. (1990) Serum concentrations of the carboxyterminal cross-linking domain of procollagen type IV (NC1) and the aminoterminal propeptide of procollagen type III (PIIIP) in chronic liver disease. J. Hepatol. 10, 17-22.
113. Schuppan, D., Besser, M., Schwarting, R. & Hahn, E. G.(1986) Radioimmunoassay for the carboxy-terminal crosslinking domain of type IV (basement membrane) procollagen in body fiuids. J. Clin. Invest. 78, 241-248.
114. Risteli, J., Niemi, S., Trivedi, P., Mäentausta, O., Mowat, A. P. & Risteli, L. (1988) Rapid equilibriumradioiminunoassay for the amino-terminal propeptide of human type III procollagen. Clin. Chem. 34, 715-718.
115. Hartraann, D. J., Trinchet, J.C., Ricard-Blum, S., Beaugrand, M., Callard, P. & Ville, G. (1990) Radioimmunoassay of type I collagen that iriainly detects degradation products in serum: Application to patients with liver diseases. Clin. Chem. 36, 421-426.
116. Melkko, J., Niemi, S., Risteli, L. & Risteli, J. (1990) Radioimmunoassay of the carboxytermirial propeptide of human type I procollagen. Clin. Chem. 36, 1328-1332.
117. Kropf, J., Gressner, A. M. & Negwer, A. (1988) Efficacy of serum laminin measurement for diagnosis of fibrotic diseases. Clin. Chem. 34, 2026-2030.
118. Misaki, M., Shima, T., Yano, Y., Sumita, Y., Kano, U., Murata, T., Watanabe, S. & Suzuki, S. (1990) Basement membrane-related and type III procollagen-related antigens in serum of patients with chronic viral liver disease. Clin. Chem. 36, 522-524.
119. Robert, P. Champigneulle, B., Kreher, L., Gueant, J. L., Foliguet, B., Dollet, J.-M., Bigard, M.-A. & Gaucher, P. (1989) Evaluation of fibrosis in the Disse space in noncir-rhotic alcoholic liver disease. Alcohotism: Clin. Exp. Res. 13, 176-180.
120. Niemelä, O., Risleli, J., Blake, J. E., Risteli, L., Compton, K. V. & Orrego, H. (1990) Markers of fibrogenesis and bascment membrane formation in alcoholic liver discase. Gaslrocnlerology 98, 1621-1619.
121. Engslröm-Laurent, A., Löf, L., Nyberg, A. & Schröder, T. (1985) Increased scrum levels of hyaluronate in liver disease. Hepatology 5, 638-642.
122. Nyberg, A., Engström-Laurent, A. & Löf, L. (1988) Serum hyaluronate in primary biliary cirrhosis — a biochemical marker for progressive liver damage. Hepatology 8, 142-146.
123. Surrenti, C., Casini, A., Milani, S., Ambu, S., Ceccatelli, P. & D’Agata, A. (1987) 1s determination of serum Nterminal procollagen type III peptide (sPIIIP) a marker of hepalic fibrosis? Digest. Dis. Sci. 32, 705-709.
124. Annoni, G., Colombo, M., Cantaluppi, M. C., Khlat, B., Lampertico, P. & Rojkind, M. (1989) Serum type III procollagen peptide and laminin (lam-Pl) detect alcoholic hepatitis in chronic alcohol abusers. Hepatology 9, 693—697.
125. McCullough, A. J., Stassen, W. N., Wiesner, R. H. & : Czaja, A. J. (1987) Serum type III procollagen peptide i concentrations in severe chronic active hepatilis: Relationship to cirrhosis and disease activity. Hepatology 7, 49-54.
126. González-Reimers, E., Brajin-Rodriguez, M. M., Rodri-guez-Moreno, F., Santolaria-Fernández, F., Batisla-Lopez, N., Alvarez-Argüelles, H., Milena, A. & Rodriguez-Hernández, A. (1990) Clinical and prognostic value of serum procollagen levels in chronic alcoholic liver disease. Drug Alcohol Depend. 25, 91 -95.
127. Alcorn, J. & Chojkier, M. (1987) Procollagen III peptide (PII1NP): Can it reflect hepatic fibrosis? Hepatology 7, 981-983.
128. Bentsen, K. D., Henriksen, J. H., Bendtsen, F., Horslev-Petersen, K. & Lorenzen, I. (1990) Splanchnic and renal extraction of circulating type III procollagen aminoterminal propetide in patients with normal liver function and in palients with alcoholic cirrhosis. Hepatology 77, 957 —963.
129. Beck, K., Hunter, I. & Engel, J. (1990) Structure and function of laminin: Anatomy of a multidomain glycoprotein. FASEB J. 4, 148-160.
130. Sato, K., Nouchi, T., Torner, T. M. & Lieber, C. S. (1986) Liver fibrosis in alcoholics. Detection by Fab radioimmunoassay of serum procollagen IILpeptides. J. Am. Med. Ass. 25(5, 1471-1473.
131. Nouchi, T., Worner, T. M., Sato, S. & Lieber, C. S. (1987) Serum procollagen type III N-terminal peptides and laminin Pl peptide in alcoholic liver disease. Alcoholism: Clin. Exp. Res. 77, 287-291.
132. Gressner, A. M. & Tittor, W. (1986) Serum laminin - its concentration increases with portal hypertension in cirrhotic liver disease. Klin. Wochenschr. 64, 1240-1248.
133. Gressner, A. M., Tittor, W., Negwer, A. & Pick-Kober, K.-H. (1986) Serum concentrations of laminin and aminoterminal propeptide of type III procollagen in relation to the portal venous pressure of fibrotic liver diseases. Clin. Chim. Acta 767, 249-258.
134. Gressner, A. M., Tittor, W. & Kröpf, J. (1988) The predictive valüe of serum laminin for portal hypertension in chronic liver diseases. Hepato-Gastroenterol. 35, 95—100.
135. Kröpf, J., Gressner, A. M. & Tittor, W. (1991) Logisticrcgression model for assessing portal hypertension by measuring hyaluronic acid (hyaluronan) and laminin in serurn. Clin. Chem. 37, 30-35.
136. Gressner, A. M., Tittor, W. & Kröpf, J. (1988) Evaluation of serum aminoterminal procollagen type III propeptide as an index of portal hypcrlension and esophageal varices in chronic liver diseases. Clin. Chim. Acta 774, 163—170.
137. Laurent, U. B. G. & Tengblad, A. (1980) Determination of hyaluronate in biological samples by a specific radioassay technique. Anal. Biochem. 109, 386—394.
138. Delpech, B., Bertrand, P. & Maingonnat, C. (1985) Imrnunoenzymoassay of the hyaluronic acid-hyaluroncctin intcraction: Application to the detection of hyaluronic acid in serum of normal subjects and cancer patients. Anal. Biochem. 149, 555-565.
139. Kongtawelert, P. & Ghosh, P. (1990) A method for the quantitation of hyaluronan (hyaluronic acid) in biological fluids using a labeled avidin-biotin technique. Anal. Biochem. 185, 313-318.
140. Kongtawelert, P. & Ghosh, P. (1989) An enzyme-linked immunosorbent-inhibition assay for quantitation of hyaluronan (hyaluronic acid) in biological fiuids. Anal. Biochem. 178, 367-372.
141. Frébourg, T., Delpech, B., Bercoff, E., Scnant, J., Bertrand, P. Deugnier, Y. & Bourreille, J. (1986) Serum hyaluronate in liver diseases: Study by enzymoimmunological assay. Hepatology 6, 392—395.
142. Henriksen, J. H., Bentsen, K. D. & Laurenl, T. C. (1988) Splanchnic and renal extraction of circulating hyaluronan in patients with alcoholic liver disease. J. Hepatol. 6, 158—166.
143. Fraser, J. R. E., Engström-Laurent, A., Nyberg, A. & Laurent, T. C. (1986) Removal of hyaluronic acid from the circulation in rheumatoid disease and primary biliary cirrhosis. J. Lab. Clin. Med. 707, 79-85.
144. Engström-Laurent, A. & Hellström, S. (1990) The role of liver and kidneys in the rcmoval of circulating hyaluronan. An experimental study in the rat. Conn. Tiss. Res. 24, 219-224.
145. Day, D. P., Bashir, R., Sykes, B., Crabbe, D. (1990) Investigation of the role of five candidate genes in genetic susceptibility of alcoholic cirrhosis. Hepatology 72, 923 (Abstract).